Researchers from Archimedes Inc., a healthcare modeling and analytics company, have reported the findings of a simulated clinical trial, “Cost-Effectiveness Of A Genetic Test For Breast Cancer Risk,” ...
SALT LAKE CITY, March 18, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, announced that the National Comprehensive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback